Effect of oral sodium bicarbonate on fibroblast growth factor-23 in patients with chronic kidney disease: a pilot study

BACKGROUND: The regulation of fibroblast growth factor-23 (FGF23) secretion in patients with chronic kidney disease (CKD) is incompletely understood. An in vitro study showed that metabolic acidosis increased FGF23 in mouse bone. The objective of this study is to evaluate the effect of oral sodium b...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Wei, Melamed, Michal L., Hostetter, Thomas H., Bauer, Carolyn, Raff, Amanda C., Almudevar, Anthony L., Lalonde, Amy, Messing, Susan, Abramowitz, Matthew K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974735/
https://www.ncbi.nlm.nih.gov/pubmed/27495287
http://dx.doi.org/10.1186/s12882-016-0331-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974735/
https://www.ncbi.nlm.nih.gov/pubmed/27495287
http://dx.doi.org/10.1186/s12882-016-0331-6

Ejemplares similares